Osaic Holdings’s Ovid Therapeutics OVID Stock Holding History

Osaic Holdings’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5	Closed	-$6	–	8071
2025 Q3	$6	Hold	5	–	–	﹤0.01%	7874
2025 Q2	$1	Hold	5	–	–	﹤0.01%	7731
2025 Q1	$1	Sell	5 -285	-98%	-$175	﹤0.01%	7416
2024 Q4	$271	Sell	290 -140	-33%	-$157	﹤0.01%	7130
2024 Q3	$507	Hold	430	–	–	﹤0.01%	7010
2024 Q2	$331	Sell	430 -16	-4%	-$45	﹤0.01%	7085
2024 Q1	$1.36K	Buy	446 +140	+46%	+$468	﹤0.01%	6604
2023 Q4	$985	Hold	306	–	–	﹤0.01%	6765
2023 Q3	$1.18K	Hold	306	–	–	﹤0.01%	6784
2023 Q2	$1K	Sell	306 -25	-8%	-$85	﹤0.01%	6880
2023 Q1	$854	Hold	331	–	–	﹤0.01%	7008
2022 Q4	$1K	Hold	331	–	–	﹤0.01%	6920
2022 Q3	$1K	Hold	331	–	–	﹤0.01%	7031
2022 Q2	$1K	Hold	331	–	–	﹤0.01%	7126
2022 Q1	$1K	Hold	331	–	–	﹤0.01%	7093
2021 Q4	$1K	Sell	331 -100	-23%	-$343	﹤0.01%	7225
2021 Q3	$1K	Buy	431 +25	+6%	+$91	﹤0.01%	7054
2021 Q2	$1K	Sell	406 -100	-20%	-$395	﹤0.01%	6872
2021 Q1	$2K	Hold	506	–	–	﹤0.01%	6507
2020 Q4	$1K	Sell	506 -25	-5%	-$117	﹤0.01%	6248
2020 Q3	$3K	Sell	531 -300	-36%	-$2.01K	﹤0.01%	5747
2020 Q2	$6K	Buy	+831	New	+$3.89K	﹤0.01%	5411

Other funds holding OVID

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Osaic Holdings's OVID Position: Q4 2025 in Review

Osaic Holdings sold out of Ovid Therapeutics (OVID) in Q4 2025, closing a stake of 5 shares — an estimated $6 sold.

Osaic Holdings first reported a position in OVID in Q2 2020 and held it in 22 quarters. The position peaked at $6K in Q2 2020. 84 funds tracked by Wall St. Rank hold OVID as of Q4 2025.

Osaic Holdings reported no remaining Ovid Therapeutics position as of Q4 2025 after selling out during the quarter.
Osaic Holdings sold 5 Ovid Therapeutics shares in Q4 2025, an estimated $6.
Osaic Holdings first reported a position in Ovid Therapeutics in Q2 2020 and held it in 22 quarters.
Osaic Holdings's Ovid Therapeutics position peaked at $6K in Q2 2020.
84 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.